In HCC cells, MIR4435-2HG can promote the phosphorylation of ERK, p38, and c-Jun N-terminal kinase (JNK), and activate the MAPK/ERK signaling pathway, thereby promoting HCC cell proliferation, cell cycle progression, and survival (20). Here, MAPK8 is linked to hepatocellular carcinoma.